N@N

Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors

_{//health-fitness.news-articles.net/content/2011/ .. -u-s-chamber-of-commerce-board-of-directors.html}
^{Published in Health and Fitness on Monday, June 13th 2011 at 4:10 GMT by Market Wire}  

ROCKVILLE, Md.--([ BUSINESS WIRE ])--Emergent BioSolutions Inc. (NYSE:EBS) announced today that its Chairman and Chief Executive Officer, Fuad El-Hibri, has been appointed to serve on the Board of Directors of the U.S. Chamber of Commerce. The U.S. Chamber of Commerce is the world's largest business federation representing the interests of more than 3 million businesses of all sizes, sectors, and regions, as well as state and local chambers and industry associations.

"Throughout his career, Fuad El-Hibri has successfully identified and expanded on business opportunities that contribute to creating jobs and growing the economy"

aI am pleased with the opportunity to serve on the Board of an organization whose mission is to advance human progress through initiative and responsibility,a said Mr. El-Hibri. aI look forward to helping move the Chambera™s agenda forward and contributing to its success.a

"Throughout his career, Fuad El-Hibri has successfully identified and expanded on business opportunities that contribute to creating jobs and growing the economy," said Thomas J. Donohue, President and CEO of the U.S. Chamber of Commerce. "Fuad is an accomplished entrepreneur and the Chamber will benefit from his vast experience in international business and partnering with the U.S. government."

Mr. El-Hibri has been at the helm of Emergent BioSolutions since its inception in 1998. Prior to Emergent, he worked extensively in the telecommunications, banking, and consulting industries. Mr. El-Hibri is chairman of the El-Hibri Charitable Foundation and serves on several boards, including that of the International Biomedical Research Alliance and the National Health Museum.

About Emergent BioSolutions Inc.

Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at [ www.emergentbiosolutions.com ].